Surgical Robots: Between Boom and Bust, Reshuffling Begins

Bot Telegraph August 17th report, the surgical robot industry is undergoing an intensive wave of IPOs. Since 2026, companies have been actively competing in the capital market to secure survival and growth opportunities. In June alone, three companies achieved key IPO milestones. On June 30, Zhen Health Medical was listed on the Hong Kong Stock Exchange, becoming the “first stock in percutaneous puncture surgical robots,” with its share price surging over 200% on the first day and its market capitalization exceeding HK$14 billion. Within the same week, the A-share IPO applications of Shurui Robot and Huake Precision were also accepted.

However, the industry also reveals complexity on another front. For example, Harbin Sizherui Intelligent Medical Equipment Co., Ltd. (abbreviated as “Sizherui”), the company behind the Kangduo Robot, has seen its IPO process come to a prolonged standstill. Sizherui applied for listing on the Science and Technology Innovation Board as early as October 31, 2022, and passed the listing committee meeting and submitted for registration in June 2023. However, as of August 2026, its review status remains “submitted for registration,” a duration of nearly three years. These three years have coincided with a phase in the domestic surgical robot industry shifting from capital frenzy to market consolidation.

Industry dynamics are not limited to the IPO level. Recently, the listed company Tianzhihang (688277.SH) disclosed plans to acquire a 62% stake in Shanghai Weichuang Orthopedic Medical Technology Co., Ltd. through share issuance, indicating a trend of leading enterprises consolidating resources.

Market fluctuations are also directly reflected in the experiences of practitioners. A product manager from a foreign surgical robot company observed that in recent years, colleagues around them have gradually left, some moving to other companies, some switching careers entirely, and the number of people still actively engaged in the industry has significantly decreased. This reflects the talent and pressure challenges the industry faces during the process of recalibrating expectations.

Source: Bot Telegraph China